Search

everythinglearnresearchcommunity

for

Search:↓

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Researchers created early-stage hair-like structures from skin cells, showing how these cells can self-organize, but more is needed for complete hair growth.

Minoxidil helps treat pattern hair loss in both men and women.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.